AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor

Guide to Receptors and Channels (GRAC), 5th edition

(2011) SPH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice

(2010) Daniele Bolognini et al.   BRITISH JOURNAL OF PHARMACOLOGY

Updating the Chemistry and Biology of Cannabinoid CB2 Receptor – Specific Inverse Agonists

(2010) Charles A. Lunn   CURRENT TOPICS IN MEDICINAL CHEMISTRY

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

(2010) R. G. Pertwee et al.   PHARMACOLOGICAL REVIEWS

Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242

(2009) I Mancini et al.   BRITISH JOURNAL OF PHARMACOLOGY

Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3

(2008) Raphael Rozenfeld et al.   FASEB JOURNAL

Biology and therapeutic potential of cannabinoid CB2receptor inverse agonists

(2007) C A Lunn et al.   BRITISH JOURNAL OF PHARMACOLOGY

In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?

(2006) B B Yao et al.   BRITISH JOURNAL OF PHARMACOLOGY